SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ethical Holdings (Ethcy) - seriously undervalued

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Dancy who wrote (319)1/26/1999 10:35:00 AM
From: tim wilson  Read Replies (1) of 345
 
interesting review of Elan on MSN ---

Elan Powers Up Its Drug Pipeline
moneycentral.msn.com
Will the Irish pharmaceuticals maker be the next Merck or Pfizer? Elan Corp.
PLC (NYSE: ELN - news) says that two years from now its sales could quadruple to
$1 billion.

the Elan connection is key to understanding the enormous opportunity w/ Ethcy;

the Elan strategy was to
1) buy control of a corporate structure, (at a very attractive price) that has some decent technology and people (below the surface)

2) put in new executive mgmt that was capable of and driven to build a business at the hundreds of millions of sales level

3) take advantage of the enormous technology and business flow that Elan sees...but Elan is only capable of going after large opportunities at their current size... and not lose the $10 -60 mil size opportunities... but instead be able to funnel them to Ethcy... and enjoy 75% of the benefits

Elan bought at $5; my guess is that they would not have been thinking about anything less than a quadruple, and potentially much more

-tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext